Viable germ cell tumor and teratoma can be distinguished from necrosis in postchemotherapy retroperitoneal lymph node dissection specimens by a combination of microRNA-371a-3p and 375-5p.

被引：0

|

作者：

Nestler, Tim

Kremer, Lara

von Brandenstein, Melanie

Koeditz, Barbara

Paffenholz, Pia

Hellmich, Martin

Pfister, David

Heidenreich, Axel

机构：

[1] Univ Hosp Cologne, Dept Urol, Cologne, Germany

[2] Univ Hosp Cologne, Dept Urol & Urooncol, Cologne, Germany

[3] Univ Cologne, Inst Med Stat & Computat Biol, Cologne, Germany

[4] Univ Hosp Cologne, Cologne, Germany

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 06期

关键词：

D O I：

10.1200/JCO.2022.40.6_suppl.421

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

421

引用

收藏

页数：2

相关论文

共 14 条

[11] The prognostic value of teratoma in the primary tumor and postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) specimens in patients with germ cell tumors (GCTs)
Taza, Fadi
Chovanec, Michal
Snavely, Anna
Adra, Nabil
Hanna, Nasser H.
Cary, Clint
Masterson, Timothy A.
Einhorn, Lawrence H.
Albany, Costantine
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[12] miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR Study
Thor, Anna
Myklebust, Mette Pernille
Bergdahl, Anna Grenabo
Lundgren, Per-Olof
Skokic, Viktor
Almas, Bjarte
Haugnes, Hege Sagstuen
Tandstad, Torgrim
Akre, Olof
Cohn-Cedermark, Gabriella
Dahl, Olav
Kjellman, Anders
JOURNAL OF UROLOGY, 2024, 212 (05): : 720 - 730
[13] Reply: miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR Study
Thor, Anna
JOURNAL OF UROLOGY, 2025, 213 (01): : 122 - 123
[14] Letter: miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR Study
Dieckmann, Klaus-Peter
Belge, Gazanfer
JOURNAL OF UROLOGY, 2025, 213 (01): : 117 - 118